📊 Score Breakdown
Offering Ability
60
Cash Runway
25
Float Risk
15
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
32%
📉 Score Deterioration
40%
• Score rose 30 points recently (worsening)
🔄 Reverse Split
30%
• 50-day avg $1.17 approaching $1 threshold
📜 Warrant Exercise
15%
• Warrant overhang: 12.5% of shares outstanding
💹 Market Data
Market Cap$8.25M
Shares Outstanding10.59M
Float10.56M
Cash$18.05M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 99.9% shares (2025Q4 vs prior)
3 institutional holders · 890 shares
#1
BANK OF AMERICA CORP /DE/
715 shares
#2
Allworth Financial LP
125 shares
#3
ELEVATION POINT WEALTH PARTNERS, LLC
50 shares
📉 Short Interest
Short Interest1.03M
Days to Cover2.9
% of Float9.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
4
INSIDER TRANSACTION
Apr 15, 2026
4
INSIDER TRANSACTION
Feb 27, 2026
4
INSIDER TRANSACTION
Feb 27, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for GNPX
📊 GNPX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GNPX Signal Convergence & Dark Pool Activity — StonkWhisper
📄 GNPX Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.